- Home
- RMCO vs MYO Comparison
RMCO vs MYO Comparison
Compare RMCO & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMCO
- MYO
- Stock Information
- Founded
- RMCO 2021
- MYO 2004
- Country
- RMCO United States
- MYO United States
- Employees
- RMCO N/A
- MYO N/A
- Industry
- RMCO Multi-Sector Companies
- MYO Industrial Specialties
- Sector
- RMCO Miscellaneous
- MYO Health Care
- Exchange
- RMCO Nasdaq
- MYO Nasdaq
- Market Cap
- RMCO 45.7M
- MYO 40.8M
- IPO Year
- RMCO N/A
- MYO 2017
- Fundamental
- Price
- RMCO $3.04
- MYO $1.11
- Analyst Decision
- RMCO Buy
- MYO Strong Buy
- Analyst Count
- RMCO 1
- MYO 3
- Target Price
- RMCO N/A
- MYO $7.83
- AVG Volume (30 Days)
- RMCO 165.1K
- MYO 2.2M
- Earning Date
- RMCO 11-14-2025
- MYO 11-07-2025
- Dividend Yield
- RMCO 0.32%
- MYO N/A
- EPS Growth
- RMCO N/A
- MYO N/A
- EPS
- RMCO N/A
- MYO N/A
- Revenue
- RMCO $2,641,171.00
- MYO $40,760,091.00
- Revenue This Year
- RMCO N/A
- MYO $24.69
- Revenue Next Year
- RMCO N/A
- MYO $20.91
- P/E Ratio
- RMCO N/A
- MYO N/A
- Revenue Growth
- RMCO 292.46
- MYO 93.08
- 52 Week Low
- RMCO $0.90
- MYO $0.80
- 52 Week High
- RMCO $4.76
- MYO $7.17
- Technical
- Relative Strength Index (RSI)
- RMCO 53.92
- MYO 52.00
- Support Level
- RMCO $2.80
- MYO $1.04
- Resistance Level
- RMCO $4.29
- MYO $1.16
- Average True Range (ATR)
- RMCO 0.52
- MYO 0.12
- MACD
- RMCO -0.05
- MYO 0.01
- Stochastic Oscillator
- RMCO 14.29
- MYO 33.87
About RMCO Royalty Management Holding Corporation
Royalty Management Holding Corp formed to invest or purchase assets that have current or near-term income to provide the company with accretive cash flow from which it can reinvest in new assets or expand cash flow from existing assets. These assets typically are natural resources assets (including real estate and mining permits), patents, intellectual property, and emerging technologies.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).